The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

Prevention of Venous Thromboembolism

Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,368 · see citing works

Prognosis of Cancers Associated with Venous Thromboembolism

Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628 · see citing works

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

Fisher, B., Costantino, J., Redmond, C. K., POISSON, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200802 · Cited by 1,466 · see citing works

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W. C., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,059 · see citing works

Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data

Levitan, N. I., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R. J., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891 · see citing works

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Clauss, M. A., Gerlach, M. L., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y.-C. E., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1535 · Cited by 831 · see citing works

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J. H., Sparling, T. G., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 689 · see citing works

Activation of blood coagulation in cancer: Trousseau's syndrome revisited

Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.bloodjournal62114 · Cited by 680 · see citing works

Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer

Prandoni, P., Lensing, A. W. A., Buller, H. R., Cogo, A., Prins, M. H., Cattelan, A. M., Cuppini, S., Noventa, F., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271604 · Cited by 671 · see citing works

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C. C., & Taylor, S. (1983) · Science · doi:10.1126/science.6192498 · Cited by 619 · see citing works

The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism

Sørensen, H. T., Mellemkjær, L., Steffensen, F. H., Olsen, J. H., & Nielsen, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381701 · Cited by 618 · see citing works

Activation of blood coagulation in cancer: Trousseau's syndrome revisited

Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.14 · Cited by 595 · see citing works

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Buller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 581 · see citing works

In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease

Contrino, J., Hair, G. A., Kreutzer, D. L., & Rickles, F. R. (1996) · Nature Medicine · doi:10.1038/nm0296-209 · Cited by 535 · see citing works

Venous thromboembolism and cancer

Baron, J. A., Gridley, G., Weiderpass, E., Nyrén, O., & Linet, M. S. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10018-6 · Cited by 512 · see citing works

Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Levine, M. N., Hirsh, J., Arnold, A., Gent, M., Levine, M. N., Arnold, A., Bramwell, V. H. C., Pritchard, K. I., Stewart, D., Warr, D. G., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 508 · see citing works

Phlegmasia alba dolens.

Trousseau, A. (1865) · Medical Entomology and Zoology · Cited by 502 · see citing works

Cultured human endothelial cells generate tissue factor in response to endotoxin.

Colucci, M., Balconi, G., Lorenzet, R., Pietra, A., Locati, D., Donati, M. B., & Semeraro, N. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110945 · Cited by 500 · see citing works

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.

Zhang, Y., Deng, Y., Luther, T., Müller, M., Ziegler, R., Waldherr, R., Stern, D., & Nawroth, P. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117451 · Cited by 481 · see citing works

Deep vein thrombosis of the leg

Kakkar, V. V., Howe, C. T., Nicolaides, A. N., Renney, J. T. G., & Clarke, M. (1970) · The American Journal of Surgery · doi:10.1016/s0002-9610(70)80023-x · Cited by 475 · see citing works

The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer

Levine, M. N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M. D. E., Hryniuk, W., & Pauw, S. D. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180703 · Cited by 410 · see citing works

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

Saphner, T. J., Tormey, D. C., & Gray, R. G. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.2.286 · Cited by 401 · see citing works

Structure and function of thrombomodulin: a natural anticoagulant

Dittman, W., & Majerus, P. (1990) · Blood · doi:10.1182/blood.v75.2.329.bloodjournal752329 · Cited by 383 · see citing works

Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture

Moore, K., Esmon, C., & Esmon, N. L. (1989) · Blood · doi:10.1182/blood.v73.1.159.159 · Cited by 336 · see citing works

Structure and function of thrombomodulin: a natural anticoagulant

Dittman, W., & Majerus, P. (1990) · Blood · doi:10.1182/blood.v75.2.329.329 · Cited by 328 · see citing works

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

Abé, K., Shoji, M., Jiang, C., Bierhaus, A., Danave, I. R., Micko, C. J., Casper, K. A., Dillehay, D. L., Nawroth, P. P., & Rickles, F. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8663 · Cited by 311 · see citing works

Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis

Raz, A., & Lotan, R. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00144274 · Cited by 299 · see citing works

Hemostatic alterations in cancer patients

Rickles, F. R., Levine, M. N., & Edwards, R. L. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307180 · Cited by 281 · see citing works

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

Pritchard, K. I., Paterson, A. H. G., Paul, N., Zee, B. C.-Y., Fine, S., & Pater, J. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2731 · Cited by 269 · see citing works

Pathophysiology of the Thrombophilic State in the Cancer Patient

Falanga, A., & Rickles, F. R. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994919 · Cited by 249 · see citing works

Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

Shoji, M., Hancock, W. W., Abé, K., Micko, C. J., Casper, K. A., Baine, R. M., Wilcox, J. N., Danave, I. R., Dillehay, D. L., Matthews, E., et al. (1998) · Europe PMC (PubMed Central) · Cited by 248 · see citing works

PREVENTION OF FATAL POSTOPERATIVE PULMONARY EMBOLISM BY LOW DOSES OF HEPARIN *1An International Multicentre Trial

(1975) · The Lancet · doi:10.1016/s0140-6736(75)90494-8 · Cited by 242 · see citing works

Deep venous thrombosis and occult malignancy: an epidemiological study

Nordström, M., Lindblad, B., Anderson, H., Bergqvist, D., & Kjellström, T. (1994) · BMJ · doi:10.1136/bmj.308.6933.891 · Cited by 235 · see citing works

Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formationa

Dvorak, H. F., Nagy, J. A., Berse, B., Brown, L. F., Yeo, K.-T., YEO, T., Dvořàk, A. M., Water, L. V. D., Sioussat, T. M., & Senger, D. R. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51603.x · Cited by 229 · see citing works

The tissue factor pathway of blood coagulation.

Nemerson, Y. (1992) · PubMed · Cited by 223 · see citing works

The Impact of All-trans-Retinoic Acid on the Coagulopathy of Acute Promyelocytic Leukemia

Barbui, T., Finazzi, G., & Falanga, A. (1998) · Blood · doi:10.1182/blood.v91.9.3093 · Cited by 217 · see citing works

Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue

Falanga, A., & Gordon, S. G. (1985) · Biochemistry · doi:10.1021/bi00341a041 · Cited by 211 · see citing works

Vascular endothelial growth factor–stimulated endothelial cells promote adhesion and activation of platelets

Verheul, H. M. W., Jorna, A. S., Hoekman, K., Broxterman, H. J., Gebbink, M. F. B. G., & Pinedo, H. M. (2000) · Blood · doi:10.1182/blood.v96.13.4216 · Cited by 210 · see citing works

Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75

Zacharski, L. R. (1981) · JAMA · doi:10.1001/jama.245.8.831 · Cited by 207 · see citing works

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen

Goodnough, L. T., Saito, H., Manni, A., Jones, P. K., & Pearson, O. H. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7 · Cited by 200 · see citing works

Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.

Pearlstein, E., Salk, P. L., Yogeeswaran, G., & Karpatkin, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4336 · Cited by 192 · see citing works

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

Chahinian, A. P., PROPERT, K. J., Ware, J., Zimmer, B., Perry, M. C., Hirsh, V., Skarin, A. T., Kopel, S., Holland, J. F., & Comis, R. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.993 · Cited by 190 · see citing works

Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.

(1975) · PubMed · Cited by 189 · see citing works

The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient

Lee, A. Y. Y., & Levine, M. N. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994915 · Cited by 182 · see citing works

Tissue Factor in Health and Disease

Semeraro, N., & Colucci, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657625 · Cited by 182 · see citing works

VEGF induces hyperpermeability by a direct action on endothelial cells

Hippenstiel, S., Krüll, M., Ikemann, A., Risau, W., Clauss, M. A., & Suttorp, N. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.274.5.l678 · Cited by 181 · see citing works

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

Green, D., Hull, R., Brant, R., & Pineo, G. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)92064-m · Cited by 164 · see citing works

The prethrombotic state in cancer.

Luzzatto, G., & Schafer, A. I. (1990) · PubMed · Cited by 163 · see citing works

Neutrophil Activation and Hemostatic Changes in Healthy Donors Receiving Granulocyte Colony-Stimulating Factor

Falanga, A., Marchetti, M., Evangelista, V., Manarini, S., Oldani, E., Giovanelli, S., Galbusera, M., Cerletti, C., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.8.2506 · Cited by 157 · see citing works

Platelets and Cancer Metastasis: More Than an Epiphenomenon

Honn, K. V., Tang, D. G., & Chen, Y. Q. (1992) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002578 · Cited by 149 · see citing works

Occult Cancer in Patients with Venous Thromboembolism: which Patients, which Cancers

Monréal, M., Llamazares, J. F., Perandreu, J., Urrútia, A., Sahuquillo, J. C., & Contel, E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657740 · Cited by 146 · see citing works

Cancer and Thrombosis: from Phlegmasia Alba Dolens to Transgenic Mice

Donati, M. B. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642690 · Cited by 144 · see citing works

Role of Platelets, Thrombin, Integrin llb-llla, Fibronectin and Von Willebrand Factor on Tumor Adhesion in Vitro and Metastasis in Vivo

Nierodzik, M. L., Klepfish, A., & Karpatkin, S. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642691 · Cited by 143 · see citing works

HYPERCOAGULABILITY IN CANCER

Green, K. B., & Silverstein, R. L. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70349-x · Cited by 138 · see citing works

Importance of Findings on the Initial Evaluation for Cancer in Patients with Symptomatic Idiopathic Deep Venous Thrombosis

Cornuz, J., Pearson, S. D., Creager, M. A., Cook, E. F., & Goldman, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-10-199611150-00001 · Cited by 136 · see citing works

Tissue factor expression and angiogenesisin human prostate carcinoma

Abdulkadir, S. A., Carvalhal, G. F., Kaleem, Z., Kisiel, W., Humphrey, P. A., Catàlona, W. J., & Milbrandt, J. (2000) · Human Pathology · doi:10.1053/hp.2000.6547 · Cited by 130 · see citing works

Thrombotic Complications of Central Venous Catheters in Cancer Patients

Bona, R. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994916 · Cited by 121 · see citing works

Insulin secretion and action in patients with pancreatic cancer

Cersósimo, E., Pisters, P. W. T., Pesola, G. R., McDermott, K., Bajorunas, D. R., & Brennan, M. F. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2 · Cited by 119 · see citing works

The Prevalence and Associated Variables of Deep Venous Thrombosis in Patients with Advanced Cancer

Johnson, M. J., Sproule, M., & Paul, J. (1999) · Clinical Oncology · doi:10.1053/clon.1999.9023 · Cited by 116 · see citing works

Cellular Receptors in the Regulation of Plasmin Generation

Hajjar, K. A. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642693 · Cited by 116 · see citing works

Cancer Procoagulant and Tissue Factor Are Differently Modulated by All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Cells

Falanga, A., Consonni, R., Marchetti, M., Locatelli, G., Garattini, E., Gambacorti-Passerini, C. B., Gordon, S. G., & Barbui, T. (1998) · Blood · doi:10.1182/blood.v92.1.143.413k18_143_151 · Cited by 115 · see citing works

Cancer procoagulant in human tumor cells: evidence from melanoma patients.

Donati, M. B., Gambacorti-Passerini, C. B., Casali, B., Falanga, A., Vannotti, P., Fossati, G., Semeraro, N., & Gordon, S. G. (1986) · PubMed · Cited by 113 · see citing works

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.

Clahsen, P. C., van de Velde, C. J., Julien, J. P., Floiras, J. L., & Mignolet, F. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1266 · Cited by 112 · see citing works

Characterization of the platelet-aggregating activity of tumor cells.

Hara, Y., Steiner, M., & BALDINI, M. G. (1980) · PubMed · Cited by 110 · see citing works

Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters

Dublin, E. A., Patel, N. K., Gillett, C., Smith, P., Peters, G. G., & Barnes, D. M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1 · Cited by 109 · see citing works

All‐trans‐RETINOIC ACID INCREASES ADHESION TO ENDOTHELIUM OF THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE NB4

Marchetti, M., Falanga, A., Giovanelli, S., Oldani, E., & Barbui, T. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4911029.x · Cited by 107 · see citing works

Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy

Levine, M. N. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657515 · Cited by 103 · see citing works

Fibrin activation of vascular endothelial cells. Induction of IL-8 expression

Qi, J., & Kreutzer, D. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.867 · Cited by 99 · see citing works

The incidence of occult cancer in patients with deep venous thrombosis: a prospective study

Bastounis, E., Karayiannakis, A. J., Makri, G. G., Alexiou, D., & Papalambros, E. L. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.426000.x · Cited by 96 · see citing works

Prevention of Post-operative Deep Leg Vein Thrombosis in Patients with Cancer

Gallus, A. S. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657514 · Cited by 91 · see citing works

Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor

Blann, A. D., Gurney, D. A., Wadley, M., Bareford, D., Stonelake, P. S., & Lip, G. Y. H. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200101000-00007 · Cited by 89 · see citing works

Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues

Lorenzet, R., Péri, G., Locati, D., Allavena, P., Colucci, M., Semeraro, N., Mantovani, A., & Donati, M. B. (1983) · Blood · doi:10.1182/blood.v62.2.271.271 · Cited by 88 · see citing works

Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A cancer and leukemia group B study

Wall, J. G., Weiss, R. B., Norton, L., Perloff, M., Rice, M. A., Korzun, A. H., & Wood, W. C. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80604-7 · Cited by 85 · see citing works

Prevention of Venous Thromboembolism in Cancer Patients

Kakkar, A. K., & Williamson, R. C. N. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994925 · Cited by 82 · see citing works

Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

Falanga, A., Ofosu, F. A., Cortelazzo, S., Delaini, F., Consonni, R., Caccia, R., Longatti, S., Maran, D., Rodeghiero, F., Pogliani, E., et al. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03218.x · Cited by 82 · see citing works

Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs

Girolami, A., Prandoni, P., Zanon, E., Bagatella, P., & Girolami, B. (1999) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199912000-00001 · Cited by 81 · see citing works

Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy

Falanga, A. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022405 · Cited by 79 · see citing works

Occult cancer in patients with bilateral deep-vein thrombosis

Rance, A., Emmerich, J., Guedj, C., Fiessinger, J., & Emmerich, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)64210-9 · Cited by 78 · see citing works

Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation

Andoh, K., Kubota, T., Takada, M., Tanaka, H., Kobavashi, N., & Maekawa, T. (1987) · Cancer · doi:10.1002/1097-0142(19870215)59:4 · Cited by 75 · see citing works

Fibrinolysis and Cancer

Kwaan, H. C., & Keer, H. N. (1990) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002674 · Cited by 73 · see citing works

Antithrombotic Strategies in Patients with Cancer

Prandoni, P. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657517 · Cited by 72 · see citing works

Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism

Rickles, F. R., & Levine, M. N. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022404 · Cited by 71 · see citing works

Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung.

Zacharski, L. R., Schned, A. R., & Sorenson, G. D. (1983) · PubMed · Cited by 71 · see citing works

Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis

Barbul, T., Finazzi, G., Grassi, A., & Marchioli, R. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650276 · Cited by 70 · see citing works

Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis

Edwards, R. L., Silver, J., Rickles, F. R., & Subcommittee), (. T. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651580 · Cited by 70 · see citing works

Thrombotic Complications of Central Venous Catheters in Cancer Patients

Monreal, M., & Davant, E. (2001) · Acta Haematologica · doi:10.1159/000046591 · Cited by 64 · see citing works

Guidelines for Clotting Studies in Cancer Patients

Falanga, A., Barbui, T., Rickles, F. R., & Levine, M. N. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649619 · Cited by 63 · see citing works

Platelets in tumor metastasis: generation of adenosine diphosphate by tumor cells is specific but unrelated to metastatic potential

Grignani, G., & Jamieson, G. (1988) · Blood · doi:10.1182/blood.v71.4.844.844 · Cited by 63 · see citing works

New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia

Tallman, M. S., Hakimian, D., Kwaan, H. C., & Rickles, F. R. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309054728 · Cited by 60 · see citing works

An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.

Gordon, S. G., & Cross, B. (1990) · PubMed · Cited by 55 · see citing works

Cancer Procoagulant in Acute Non Lymphoid Leukemia: Relationship of Enzyme Detection to Disease Activity

Donati, M. B., Falanga, A., Consonni, R., Alessio, M. G., Bassan, R., Buelli, M., Borin, L. M., Catani, L., Pogliani, E., Gugliotta, L., et al. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647145 · Cited by 55 · see citing works

Cysteine proteinase procoagulant from amnion-chorion

Sg, G., Hasiba, U., Cross, B. A., Poole, M., & Falanga, A. (1985) · Blood · doi:10.1182/blood.v66.6.1261.1261 · Cited by 55 · see citing works

All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4)

Falanga, A., Marchetti, M., Giovanelli, S., & Barbui, T. (1996) · Blood · doi:10.1182/blood.v87.2.613.bloodjournal872613 · Cited by 52 · see citing works

Cancer Cell Procoagulants and Their Role in Malignant Disease

Gordon, S. J. G. (1992) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002580 · Cited by 51 · see citing works

Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.

Gastpar, H. (1977) · PubMed · Cited by 51 · see citing works

Production of an active urokinase by leukemia cells: A novel distinction from cell lines of solid tumors

Stephens, R. W., Alitalo, R., Tapiovaara, H., & Vaheri, A. I. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90061-6 · Cited by 50 · see citing works

The hypercoagulable state in cancer patients

Falanga, A., Ofosu, F. A., Delaini, F., Oldani, E., Dewar, L., Lui, L. C., & Barbui, T. (1994) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199401000-00004 · Cited by 49 · see citing works

Human breast and colon carcinomas express cysteine proteinase activities with pro‐aggregating and pro‐coagulant properties

Grignani, G., Falanga, A., Pacchiarini, L., Alessio, M. G., Zucchella, M., Fratino, P., & Donati, M. B. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420414 · Cited by 48 · see citing works

Deep Vein Thrombosis as a Predictor of Cancer

Ahmed, Z., & Mohyuddin, Z. (1996) · Angiology · doi:10.1177/000331979604700307 · Cited by 46 · see citing works

PREVENTION OF VENOUS THROMBO‐EMBOLISM

Fletcher, J., Mclellan, D., Cade, J. F., Fisher, C., Gibbs, H. H., Stacey, M. C., & Vedig, A. E. (1999) · Australian and New Zealand Journal of Surgery · doi:10.1046/j.1440-1622.1999.01487.x · Cited by 46 · see citing works

Molecular Mechanisms Linking Thrombosis and Angiogenesis in Cancer

Shoji, M., Abé, K., Nawroth, P. P., & Rickles, F. R. (1997) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(96)00142-9 · Cited by 45 · see citing works

Beta‐thromboglobulin and platelet‐factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy

Al-Mondhiry, H. A. B. (1983) · American Journal of Hematology · doi:10.1002/ajh.2830140202 · Cited by 44 · see citing works

Warfarin Is Safe as Secondary Prophylaxis in Patients With Cancer and a Previous Episode of Venous Thrombosis

Bona, R., Hickey, A. D., & Wallace, D. M. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200002000-00020 · Cited by 41 · see citing works

8 Venous thromboembolism and cancer

Kakkar, A. K., Lorenzo, F., Pineo, G. F., & Williamson, R. C. (1998) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(98)80089-9 · Cited by 40 · see citing works

Cancer and Deep Venous Thrombosis

Monréal, M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380020229035 · Cited by 39 · see citing works

Antithrombotic therapy in cancer

Kakkar, A. K., & Williamson, R. C. (1999) · BMJ · doi:10.1136/bmj.318.7198.1571 · Cited by 37 · see citing works

Analysis of serum cancer procoagulant activity and its possible use as a tumor marker

Gordon, S. G., & Benson, B. A. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90256-9 · Cited by 36 · see citing works

Diagnostic Value of Fibrinopeptide A and Beta‐Thromboglobulin in Acute Deep Venous Thrombosis and Pulmonary Embolism

van Hulsteijn, H., Briët, E., Koch, C., Hermans, J., & Bertina, R. M. (1982) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1982.tb01956.x · Cited by 34 · see citing works

The site of activation of factor X by cancer procoagulant

Gordon, S. G., & Mourad, A. M. (1991) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199112000-00007 · Cited by 33 · see citing works

Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies

Semeraro, N., Montemurro, P., Conese, M., Giordano, P., Stella, M., Restaino, A., Cagnazzo, G., & Colucci, M. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450208 · Cited by 32 · see citing works

Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells.

Gianni’, M., Norio, P., Terao, M., Falanga, A., Marchetti, M., Rambaldi, A., & Garattini, E. (1995) · PubMed · Cited by 28 · see citing works

Induction of monocyte-macrophage procoagulant activity by transformed cell lines.

Rambaldi, A., Alessio, G., Casali, B., Passerini, C. G., Donati, M. B., Mantovani, A., & Semeraro, N. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3848 · Cited by 27 · see citing works

Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients

Rozen, P., Lubin, F., Papo, N., Knaani, J., Farbstein, H., Farbstein, M., & Zajicek, G. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4 · Cited by 27 · see citing works

Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant

Mielicki, W. P., & Gordon, S. G. (1993) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199306000-00008 · Cited by 26 · see citing works

Alterations in platelet surface sialytransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis.

Scialla, S. J., Speckart, S. F., Haut, M. J., & Kimball, D. B. (1979) · PubMed · Cited by 26 · see citing works

Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture

Moore, K., Esmon, C., & Esmon, N. L. (1989) · Blood · doi:10.1182/blood.v73.1.159.bloodjournal731159 · Cited by 24 · see citing works

Lack of association between venous thrombosis and subsequent malignancy in a retrospective cohort study in young patients

Subir�, M., Mateo, J., Souto, J. C., Alt�s, A., & Fontcuberta, J. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199903)60:3 · Cited by 22 · see citing works

“Idiopathic” Deep Venous Thrombosis: The Value of Routine Abdominal and Pelvic Computed Tomographic Scanning

Sannella, N. A., & O’Connor, D. J. (1991) · Annals of Vascular Surgery · doi:10.1007/bf02329376 · Cited by 22 · see citing works

Vascular endothelial growth factor–stimulated endothelial cells promote adhesion and activation of platelets

Verheul, H. M. W., Jorna, A. S., Hoekman, K., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4216.h8004216_4216_4221 · Cited by 17 · see citing works

Evaluation of β thromboglobulin levels in cancer patients : Effects of antitumor chemotherapy

Jm, B., Ferrière, J.-P., Besse, G. H., Chollet, P. J. M., Gaillard, G., & Plagne, R. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90272-8 · Cited by 15 · see citing works

Plasma membrane vesicles as mediators of interactions between tumor cells and components of the hemostatic and immune systems.

Gj, G., & Gasic, T. B. (1982) · PubMed · Cited by 12 · see citing works

Anionic Dyes, Heparin, and Heparinoids: The Rediscovery of Polyanionic Tumor Inhibitors

Regelson, W. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1929 · Cited by 11 · see citing works

Cancer and deep venous thrombosis

Monreal, M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.2.485 · Cited by 11 · see citing works

Expression of Plasminogen Activator as a Marker of Stimulation in Tumor-Associated Macrophages

Mussoni, L., & Donati, M. B. (2009) · Haemostasis · doi:10.1159/000215784 · Cited by 10 · see citing works

Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacologic Strategy toward Prevention of Metastases

Karpatkin, S., & Pearlstein, E. (1984) · Springer eBooks · doi:10.1007/978-1-4613-3831-4_11 · Cited by 8 · see citing works

Mechanisms of Platelet Aggregation by Murine Tumor Cell Sheddings

Gasic, G., Gasic, T. B., & Stewart, G. J. (1984) · Springer eBooks · doi:10.1007/978-1-4613-3831-4_10 · Cited by 7 · see citing works

Alterations in platelet surface sialyltransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis

Bingham, H. G. (1980) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-198001000-00101 · Cited by 6 · see citing works

Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis

(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3 · see citing works

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123 · see citing works

Tumors as Organs: Complex Tissues that Interface with the Entire Organism

Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,230 · see citing works

American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

Lyman, G. H., Khorana, A. A., Falanga, A., Clarke‐Pearson, D. L., Flowers, C. R., Jahanzeb, M., Kakkar, A. K., Kuderer, N. M., Levine, M. N., Liebman, H. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1283 · Cited by 942 · see citing works

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 568 · see citing works

Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study

Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H. (2005) · Cancer · doi:10.1002/cncr.21496 · Cited by 564 · see citing works

Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

Gazzerro, P., Proto, M., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 458 · see citing works

Risk factors for venous and arterial thrombosis.

Previtali, E., Bucciarelli, P., Passamonti, S. M., & Martinelli, I. (2011) · PubMed Central · doi:10.2450/2010.0066-10 · Cited by 456 · see citing works

New insights into the mechanisms of venous thrombosis

Mackman, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60229 · Cited by 436 · see citing works

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

Ay, C., Simanek, R., Vormittag, R., Dunkler, D., Alguel, G., Koder, S., Kornek, G. V., Marosi, C., Wagner, O. F., Zielinski, C. C., et al. (2008) · Blood · doi:10.1182/blood-2008-02-142422 · Cited by 420 · see citing works

Venous thromboembolism and prognosis in cancer

Khorana, A. A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.023 · Cited by 413 · see citing works

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations

Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397 · see citing works

Chemotherapy-induced thrombosis

Haddad, T. C., & Greeno, E. W. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.10.015 · Cited by 355 · see citing works

Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330 · see citing works

Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers

Widakowich, C., de Castro, G., de Azambuja, E., Dinh, P., & Awada, A. H. (2007) · The Oncologist · doi:10.1634/theoncologist.12-12-1443 · Cited by 325 · see citing works

Association between incident cancer and subsequent stroke

Navi, B. B., Reiner, A. S., Kamel, H., Iadecola, C., Elkind, M. S. V., Panageas, K. S., & DeAngelis, L. M. (2014) · Annals of Neurology · doi:10.1002/ana.24325 · Cited by 258 · see citing works

Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans

Breitbach, C. J., Arulanandam, R., Silva, N. D., Thorne, S. H., Patt, R. H., Daneshmand, M., Moon, A., Ilkow, C. S., Burke, J., Hwang, T.-H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2687 · Cited by 258 · see citing works

The prothrombotic state in cancer: pathogenic mechanisms

Cicco, M. D. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.10.003 · Cited by 238 · see citing works

Enhancement of EPR Effect for Passive Tumor Targeting: Current Status and Future Perspectives

Vagena, I.-A., Malapani, C., Gatou, Μ.-A., Lаgopati, N., & Pavlatou, E. A. (2025) · Applied Sciences · doi:10.3390/app15063189 · Cited by 232 · see citing works

Cryptogenic Stroke

Yaghi, S. R., Bernstein, R. A., PASSMAN, R. S., Okin, P. M., & Furie, K. L. (2017) · Circulation Research · doi:10.1161/circresaha.116.308447 · Cited by 195 · see citing works

Anticoagulation Strategies in Patients With Cancer

Mosarla, R. C., Vaduganathan, M., Qamar, A., Moslehi, J. J., Piazza, G., & Giugliano, R. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.017 · Cited by 181 · see citing works

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States

Potts, J. E., Iliescu, C., Lopez‐Mattei, J., Martinez, S. C., Holmvang, L., Ludman, P., de Belder, M., Kwok, C. S., Rashid, M. O., Fischman, D. L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy769 · Cited by 177 · see citing works

Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells

Jackson, J. M., Witek, M. A., Kamande, J. W., & Soper, S. A. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00016b · Cited by 172 · see citing works

Machine learning-based models for the prediction of breast cancer recurrence risk

Zuo, D., Yang, L., Jin, Y. Q., Qi, H., Liu, Y., & Li, R. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02377-z · Cited by 166 · see citing works

Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolism

van der Hulle, T., den Exter, P. L., Kooiman, J., van der Hoeven, J. J. M., Huisman, M. V., & Klok, F. A. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12605 · Cited by 153 · see citing works

Tumor-Induced NETosis as a Risk Factor for Metastasis and Organ Failure

Cedervall, J., Zhang, Y., & Olsson, A.-K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3051 · Cited by 146 · see citing works

Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis

Rumbaut, R. E., & Thiagarajan, P. (2010) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00007ed1v01y201002isp004 · Cited by 140 · see citing works

Stroke and Cancer- A Complicated Relationship.

Dearborn, J. L., Urrutia, V., & Zeiler, S. R. (2014) · PubMed · Cited by 137 · see citing works

Death causes in breast cancer patients

Riihimäki, M., Thomsen, H., Brandt, A., Sundquist, J., & Hemminki, K. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr160 · Cited by 136 · see citing works

Extracellular vesicles and particles impact the systemic landscape of cancer

Lucotti, S., Kenific, C. M., Zhang, H., & Lyden, D. C. (2022) · The EMBO Journal · doi:10.15252/embj.2021109288 · Cited by 134 · see citing works

Pulmonary tumor thrombotic microangiopathy: a systematic review

Godbole, R. H., Saggar, R., & Kamangar, N. (2019) · Pulmonary Circulation · doi:10.1177/2045894019851000 · Cited by 123 · see citing works

Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome

Chen, Q., Tong, S., Dewhirst, M. W., & Yuan, F. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1311.3.10 · Cited by 122 · see citing works

Understanding and managing the possible adverse effects associated with bevacizumab

Shord, S. S., Bressler, L. R., Tierney, L. A., Cuéllar, S., & George, A. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080455 · Cited by 122 · see citing works

Thromboembolic Events in Gastric Cancer: High Incidence in Patients Receiving Irinotecan- and Bevacizumab-Based Therapy

Shah, M. A., Ilson, D. H., & Kelsen, D. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.81.908 · Cited by 119 · see citing works

Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival

Saadeh, F. A., Norris, L., O’Toole, S. A., & Gleeson, N. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.06.004 · Cited by 113 · see citing works

Coronary Embolism Among ST-Segment–Elevation Myocardial Infarction Patients

Popovic, B., Agrinier, N., Bouchahda, N., Pinelli, S., Maigrat, C. H., Metzdorf, P. A., Selton‐Suty, C., Juillière, Y., & Camenzind, E. (2018) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.117.005587 · Cited by 107 · see citing works

Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis

Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98 · see citing works

Stroke risk factor, pattern and outcome in patients with cancer

Zhang, Y.-Y., Chan, D. K. Y., Cordato, D. J., Shen, Q., & Sheng, A. Z. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00709.x · Cited by 96 · see citing works

Cryptogenic Subtype Predicts Reduced Survival Among Cancer Patients With Ischemic Stroke

Navi, B. B., Singer, S., Merkler, A. E., Cheng, N. T., Stone, J. B., Kamel, H., Iadecola, C., Elkind, M. S. V., & DeAngelis, L. M. (2014) · Stroke · doi:10.1161/strokeaha.114.005784 · Cited by 96 · see citing works

Preoperative Anemia Predicts Thrombosis and Free Flap Failure in Microvascular Reconstruction

Hill, J. B., Patel, A., Corral, G. A. D., Sexton, K. W., Ehrenfeld, J. M., Guillamondegui, O. D., & Shack, R. B. (2012) · Annals of Plastic Surgery · doi:10.1097/sap.0b013e31823ed606 · Cited by 90 · see citing works

Tumoral pulmonary hypertension

Price, L., Seckl, M. J., Dorfmüller, P., & Wort, S. J. (2019) · European Respiratory Review · doi:10.1183/16000617.0065-2018 · Cited by 89 · see citing works

Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice

Nouh, A. M., Hussain, M., Mehta, T., & Yaghi, S. R. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00037 · Cited by 87 · see citing works

Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA

Kwok, C. S., Wong, C. W., Kontopantelis, E., Barac, A., Brown, S.-A. N., Velagapudi, P., Hilliard, A. A., Bharadwaj, A. S., Alraies, M. C., Mohamed, M., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1032 · Cited by 87 · see citing works

Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis

Zamagni, E., Brioli, A., Tacchetti, P., Zannetti, B. A., Pantani, L., & Cavo, M. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273085 · Cited by 87 · see citing works

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice

Cedervall, J., Dragomir, A., Saupe, F., Zhang, Y., Ärnlöv, J., Larsson, E., Dimberg, A., Larsson, A. O., & Olsson, A. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1320009 · Cited by 86 · see citing works

Myocardial infarction and future risk of cancer in the general population—the Tromsø Study

Rinde, L. B., Småbrekke, B., Hald, E. M., Brodin, E. E., Njølstad, I., Mathiesen, E. B., Løchen, M., Wilsgaard, T., Brækkan, S. K., Vik, A., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0231-5 · Cited by 85 · see citing works

Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke

Navi, B. B., Marshall, R. S., Bobrow, D., Singer, S., Stone, J. B., DeSancho, M. T., & DeAngelis, L. M. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4211 · Cited by 84 · see citing works

Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention

Hess, C. N., Roe, M. T., Clare, R. M., Chiswell, K., Kelly, J., Tcheng, J. E., Hagström, E., James, S. K., Khouri, M. G., Hirsch, B. R., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001779 · Cited by 84 · see citing works

The immunoregulatory glycan‐binding protein galectin‐1 triggers human platelet activation

Pacienza, N., Pozner, R. G., Bianco, G. A., D’Atri, L. P., Croci, D. O., Negrotto, S., Malaver, E., Gomez, R. M., Rabinovich, G. A., & Schattner, M. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-9524com · Cited by 81 · see citing works

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery

Angka, L., Khan, S., Kilgour, M. K., Xu, R. Y., Kennedy, M. A., & Auer, R. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081787 · Cited by 81 · see citing works

The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen)

Kell, D. B., & Pretorius, E. (2014) · Integrative Biology · doi:10.1039/c4ib00173g · Cited by 80 · see citing works

Pancreatic cancer and thromboembolic disease, 150 years after Trousseau.

Ansari, D., Ansari, D., Andersson, R., & Andrén‐Sandberg, Å. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.06.08 · Cited by 78 · see citing works

Mechanism of Tumor-Platelet Communications in Cancer

Dudiki, T., Veleeparambil, M., Zhevlakova, I., Biswas, S., Klein, E. A., Ford, P., Podrez, E. A., & Byzova, T. V. (2023) · Circulation Research · doi:10.1161/circresaha.122.321861 · Cited by 76 · see citing works

Pulmonary tumour thrombotic microangiopathy

Price, L., Wells, A. U., & Wort, S. J. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000297 · Cited by 76 · see citing works

Nanomedicine as an emerging platform for metastatic lung cancer therapy

Landesman‐Milo, D., Ramishetti, S., & Peer, D. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9554-4 · Cited by 74 · see citing works

Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients

Zhu, L., Li, J., Chen, P., Jiang, Q., & Tang, X.-P. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1350-7 · Cited by 73 · see citing works

Coagulopathic complications in breast cancer

Caine, G. J., Stonelake, P. S., Rea, D. W., & Lip, G. Y. H. (2003) · Cancer · doi:10.1002/cncr.11702 · Cited by 73 · see citing works

Risk Factor, Pattern, Etiology and Outcome in Ischemic Stroke Patients with Cancer: A Nested Case-Control Study

Zhang, Y. Y., Cordato, D. J., Shen, Q., Sheng, A. Z., Hung, W. T., & Chan, D. K. Y. (2006) · Cerebrovascular Diseases · doi:10.1159/000097639 · Cited by 70 · see citing works

Sarcomas of the Aorta: A Systematic Review and Pooled Analysis of Published Reports

Rusthoven, C. G., Liu, A. K., Bui, M. M., Schefter, T. E., ELIAS, A. D., Lu, X. J. D., & Gonzalez, R. J. (2013) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2013.07.012 · Cited by 69 · see citing works

Thrombosis in multiple myeloma

Zangari, M., Elice, F., Fink, L. M., & Tricot, G. J. K. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.3.307 · Cited by 68 · see citing works

Silver nanoparticles promote procoagulant activity of red blood cells: a potential risk of thrombosis in susceptible population

Bian, Y., Kim, K., Ngo, T., Kim, I., Bae, O., Lim, K., & Chung, J. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0292-6 · Cited by 67 · see citing works

Venous Thromboembolism in Cancer Patients Undergoing Major Surgery

Osborne, N. H., Wakefield, T. W., & Henke, P. K. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0151-4 · Cited by 67 · see citing works

Hematologic Abnormalities in the Small Animal Cancer Patient

Childress, M. O. (2011) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2011.09.009 · Cited by 67 · see citing works

TGF-β signalling-related markers in cancer patients with bone metastasis

Baselga, J. M., Rothenberg, M. L., Tabernero, J. M., Seoane, J., Daly, T. M., Cleverly, A., Berry, B., Kloeker, S., RAY, C. A., Fill, J. A., et al. (2008) · Biomarkers · doi:10.1080/13547500701676019 · Cited by 66 · see citing works

Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process

Behrenbruch, C., Shembrey, C., Paquet‐Fifield, S., Mølck, C., Cho, H., Michael, M., Thomson, B. N. J., Heriot, A. G., & Hollande, F. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9873-2 · Cited by 66 · see citing works

Cancer-associated ischemic stroke: A retrospective multicentre cohort study

Grazioli, S., Paciaroni, M., Agnelli, G., Acciarresi, M., Alberti, A., D’Amore, C., Caso, V., Venti, M. P., Guasti, L., Ageno, W., et al. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.03.011 · Cited by 66 · see citing works

SARS-CoV-2 and cancer: Are they really partners in crime?

van Dam, P. A., Huizing, M. T., Mestach, G., Dierckxsens, S., Tjalma, W. A. A., Trinh, X. B., Papadimitriou, K., Altıntaş, S., Vermorken, J. B., Vulsteke, C., et al. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102068 · Cited by 65 · see citing works

Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment

Reitter, E. ‐., Kaider, A., Ay, C., Quehenberger, P., Marosi, C., Zielinski, C. C., & Pabinger, I. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13218 · Cited by 63 · see citing works

Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy

Musallam, K. M., Dahdaleh, F. S., Shamseddine, A. I., & Taher, A. T. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.09.008 · Cited by 61 · see citing works

Three-Month Outcomes Are Poor in Stroke Patients with Cancer Despite Acute Stroke Treatment

Cutting, S., Wettengel, M., Conners, J., Ouyang, B., & Busl, K. M. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.10.021 · Cited by 61 · see citing works

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo

Zhang, X., Wang, C., Wang, X., Zhong, T., Zhao, Y., Zhang, W.-Q., Ren, W., Huang, D., Zhang, S., Guo, Y., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79840 · Cited by 60 · see citing works

cC1qR/CR and gC1qR/p33: Observations in cancer

Peerschke, E. I. B., & Ghebrehiwet, B. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.011 · Cited by 59 · see citing works

Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression

Andreasen, E. B., Tranholm, M., Wiinberg, B., Markussen, B., & Kristensen, A. T. (2012) · Acta veterinaria Scandinavica · doi:10.1186/1751-0147-54-3 · Cited by 59 · see citing works

Statins Decrease the Occurrence of Venous Thromboembolism in Patients with Cancer

Khemasuwan, D., DiVietro, M. L., Tangdhanakanond, K., Pomerantz, S. C., & Eiger, G. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.025 · Cited by 58 · see citing works

Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Sun, X., & Zhang, H. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-43 · Cited by 58 · see citing works

New diagnosis of cancer and the risk of subsequent cerebrovascular events

Navi, B. B., Howard, G., Howard, V. J., Zhao, H., Judd, S. E., Elkind, M. S. V., Iadecola, C., DeAngelis, L. M., Kamel, H., Okin, P. M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005636 · Cited by 57 · see citing works

Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism

Sano, M., Takahashi, R., Ijichi, H., Ishigaki, K., Yamada, T., Miyabayashi, K., Kimura, G., Mizuno, S., Kato, H., Fujiwara, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320608 · Cited by 56 · see citing works

The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma

Wu, J., Chan, Y.-T., Lu, Y., Wang, N., & Feng, Y. (2023) · Medicinal Research Reviews · doi:10.1002/med.21967 · Cited by 56 · see citing works

Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection

Brown, J. A., Sanidad, K. Z., Lucotti, S., Lieber, C. M., Cox, R. M., Ananthanarayanan, A., Basu, S., Chen, J. B., Shan, M., Amir, M., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2105609 · Cited by 55 · see citing works

Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: A Review of the Literature

Tufano, A., Guida, A., Minno, M. N. D. D., Prisco, D., Cerbone, A. M., & Minno, G. D. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273090 · Cited by 55 · see citing works

Progesterone Increases Tissue Factor Gene Expression, Procoagulant Activity, and Invasion in the Breast Cancer Cell Line ZR-75-1

Kato, S., Pinto, M. P., Carvajal, A., Espinoza, N., Monso, C., Sadarangani, A., Villalón, M., Brosens, J. J., WHITE, J. O., Richer, J. K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0857 · Cited by 55 · see citing works

Endothelial dysfunction: from the particular to the general. Return to the «Old Paradigm»?

Vlasov, T. D., Ивановна, Н. И., & Shimanski, D. A. (2019) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2019-18-2-19-27 · Cited by 54 · see citing works

Hypercoagulable States in Patients with Hepatocellular Carcinoma

Samonakis, D., Κoutroubakis, I. E., Sfiridaki, A., Malliaraki, N. E., Antoniou, P., Romanos, J., & Kouroumalis, E. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000030099.13397.28 · Cited by 54 · see citing works

The Link Between Cancer and Venous Thromboembolism

Kessler, C. M. (2009) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181b01b17 · Cited by 54 · see citing works

Thrombosis in ovarian cancer: a case control study

Metcalf, R. L., Fry, D., Swindell, R., McGurk, A., Clamp, A. R., Jayson, G. C., & Hasan, J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.3 · Cited by 54 · see citing works

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis

Ramacciotti, E., Wolosker, N., Puech‐Leão, P., Zerati, A. E., Gusson, P. R., del Giglio, A., & Franco, R. F. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00179-8 · Cited by 54 · see citing works

Reviews The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression

Kołodziejczyk-Czepas, J., & Ponczek, M. B. (2013) · Współczesna Onkologia · doi:10.5114/wo.2013.34611 · Cited by 51 · see citing works

Anti-angiogenesis or pro-angiogenesis for cancer treatment: focus on drug distribution.

Huang, D., Lan, H., Liu, F., Wang, S., Chen, X., Jin, K., & Mou, X. (2015) · Europe PMC (PubMed Central) · Cited by 50 · see citing works

Risk factors for deep vein thrombosis and pulmonary embolism after traumatic injury: A competing risks analysis

Gent, J. V., Calvo, R. Y., Zander, A. L., Olson, E. J., Sise, C. B., Sise, M. J., & Shackford, S. R. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001652 · Cited by 50 · see citing works

Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients.

Todorova, V. K., Hsu, P.-C., Wei, J. Y., López‐Candales, A., Chen, J. Z., Su, L. J., & Makhoul, I. (2020) · PubMed Central · Cited by 49 · see citing works

Tumour and microparticle tissue factor expression and cancer thrombosis

Date, K. L., Hall, J., Greenman, J., Maraveyas, A., & Madden, L. A. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.11.013 · Cited by 48 · see citing works

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients

Sun, F., Peng, H.-X., Gao, Q., Li, S., Zhang, J., Chen, Q.-G., Jiang, Y., Zhang, L., Wang, X.-Z., & Ying, H. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167398 · Cited by 47 · see citing works

Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization

Rangasami, V. K., Samanta, S., Parihar, V. S., Asawa, K., Zhu, K., Varghese, O. P., Teramura, Y., Nilsson, B., Hilborn, J. G., Harris, R. A., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117291 · Cited by 47 · see citing works

Prognostic Significance of Troponin Elevation for Long-Term Mortality after Ischemic Stroke

Ahn, S., Lee, J. S., Kim, Y., Kim, B. J., Kim, Y. J., Kang, D., Kim, J. S., & Kwon, S. U. (2017) · Journal of Stroke · doi:10.5853/jos.2016.01942 · Cited by 46 · see citing works

Cancer-Associated Thrombosis

Karimi, M. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010078 · Cited by 46 · see citing works

PROXIMAL DEEP VEIN THROMBOSIS AFTER HIP REPLACEMENT FOR ONCOLOGIC INDICATIONS

Nathan, S. S., Simmons, K. A., Lin, P. P., Hann, L. E., Morris, C. D., Athanasian, E. A., Boland, P. J., & Healey, J. H. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200605000-00017 · Cited by 46 · see citing works

Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal

Ahmed, O., King, N. E., Qureshi, M. A., Choudhry, A. A., Osama, M., Zehner, C. A., Ali, A., Hamzeh, I., Palaskas, N. L., Thompson, K., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae788 · Cited by 45 · see citing works

The potential benefits of low-molecular-weight heparins in cancer patients

Robert, F. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-3 · Cited by 45 · see citing works

Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery

Carrier, M., Altman, A. D., Blais, N., Diamantouros, A., McLeod, D., Moodley, U., Nguyen, C. P., Young, S. W., & Schwenter, F. (2018) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2018.11.046 · Cited by 45 · see citing works

Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis

Cavallari, I., Verolino, G., Romano, S., & Patti, G. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-3400300 · Cited by 45 · see citing works

Predicting short and long-term mortality after acute ischemic stroke using EHR

Abedi, V., Avula, V., Razavi, S., Bavishi, S., Chaudhary, D. P., Shahjouei, S., Wang, M., Griessenauer, C. J., Li, J., & Zand, R. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117560 · Cited by 45 · see citing works

Pathophysiology of the Thrombophilic State in the Cancer Patient

Falanga, A., & Rickles, F. R. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-994919 · Cited by 249 · see citing works

The prothrombotic state in cancer: pathogenic mechanisms

Decicco, M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00267-1 · Cited by 11 · see citing works

Pathogenesis and Diagnosis of Venous Hypercoagulable States in Cancer

LL, M. S. P. (2015) · Journal of Hematology & Thromboembolic Diseases · doi:10.4172/2329-8790.1000211 · Cited by 2 · see citing works

Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients

Falanga, A., Schieppati, F., & Russo, L. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-20315-3_2 · Cited by 91 · see citing works

Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief review

Peng, Q., Zhu, J., Zhang, Y., & Jing, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38831 · Cited by 36 · see citing works